نتائج البحث

Expanding Xpert MTB/RIF Ultra® and LF-LAM testing for diagnosis of tuberculosis among HIV-positive adults admitted to hospitals in Tanzania and Mozambique: a randomized controlled trial (the EXULTANT trial).

• Authors : Mangu C; Cossa M ...

Subjects: HIV Infections*/HIV Infections*/HIV Infections*/complications ; Tuberculosis*/Tuberculosis*/Tuberculosis*/diagnosis ; Tuberculosis*/Tuberculosis*/Tuberculosis*/complications

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Aug 15; Vol. 24 (1), pp. 831. Date of Electronic Publication: 2024 Aug 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Increased tuberculosis case detection in Tanzanian children and adults using African giant pouched rats.

• Authors : Agizew TB; Anti-Persoonsmijnen Ontmijnende Product Ontwikkeling (APOPO) Tuberculosis Department, Sokoine University of Agriculture, Morogoro, Tanzania. .; Department of Biology, University of Antwerp, Antwerp, Belgium. .

Subjects: Mycobacterium tuberculosis* ; Tuberculosis*/Tuberculosis*/Tuberculosis*/diagnosis ; Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/Tuberculosis, Pulmonary*/diagnosis

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Apr 15; Vol. 24 (1), pp. 401. Date of Electronic Publication: 2024 Apr 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Diagnostic accuracy of the Xpert ® MTB/XDR assay for detection of Isoniazid and second-line antituberculosis drugs resistance at central TB reference laboratory in Tanzania.

• Authors : Maya T; Central TB Reference Laboratory, Dar es Salaam, Tanzania.; Wilfred A

Subjects: Isoniazid*/Isoniazid*/Isoniazid*/pharmacology ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/pharmacology ; Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/Mycobacterium tuberculosis*/drug effects

• Source: BMC infectious diseases [BMC Infect Dis] 2024 Jul 04; Vol. 24 (1), pp. 672. Date of Electronic Publication: 2024 Jul 04.Publisher: BioMed Central Country of Publication: England NLM ID: 100968551 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Protocol for a feasibility randomized controlled trial to evaluate the efficacy, safety and tolerability of N-acetylcysteine in reducing adverse drug reactions among adults treated for multidrug-resistant tuberculosis in Tanzania.

• Authors : Mpagama, Stellah G.^1,2 (AUTHOR) ; Mvungi, Happiness C.^1,2 (AUTHOR); Mbelele, Peter M.^1,3 (AUTHOR)

• Source: Pilot & Feasibility Studies. 4/1/2023, Vol. 9 Issue 1, p1-13. 13p.

تفاصيل العنوان

Phylogenetic lineages of tuberculosis isolates and their association with patient demographics in Tanzania.

• Authors : Mutayoba, Beatrice Kemilembe^1,2 (AUTHOR) ; Michael Hoelscher² (AUTHOR); Heinrich, Norbert² (AUTHOR)

• Source: BMC Genomics. 8/5/2022, Vol. 23 Issue 1, p1-9. 9p.

تفاصيل العنوان

Whole genome sequencing of Mycobacterium tuberculosis isolates and clinical outcomes of patients treated for multidrug-resistant tuberculosis in Tanzania.

• Authors : Katale, Bugwesa Z.^1,2 (AUTHOR); Mbelele, Peter M.^3,4 (AUTHOR); Lema, Nsiande A.⁵ (AUTHOR)

• Source: BMC Genomics. 2/21/2020, Vol. 21 Issue 1, p1-15. 15p. 1 Diagram, 5 Charts.

تفاصيل العنوان

Knowledge, attitude and practice of healthcare workers on isoniazid preventive treatment in Tanzania; a health facility-based cross-sectional study.

• Authors : Mshiu, Johnson Jeremia¹ (AUTHOR) ; Alexander, Felix Christopher¹ (AUTHOR); Rushaigo, Anelisa Martin¹ (AUTHOR)

• Source: Discover Public Health. 6/26/2024, Vol. 21 Issue 1, p1-10. 10p.

تفاصيل العنوان

Factors associated with uptake of isoniazid preventive therapy among children living with HIV in Mwanza region, Tanzania: a cross-sectional study.

• Authors : Tuwa A; Department of Community and Public Health, Busitema University Faculty of Health Sciences, Mbale, Uganda.; Department of Community and Research, Mwanza College of Health and Allied Sciences- MWACHAS, P.O.BOX 476, Mwanza, Tanzania.

Subjects: Isoniazid*/Isoniazid*/Isoniazid*/therapeutic use ; HIV Infections*/HIV Infections*/HIV Infections*/prevention & control ; Antitubercular Agents*/Antitubercular Agents*/Antitubercular Agents*/therapeutic use

• Source: BMC public health [BMC Public Health] 2024 Aug 15; Vol. 24 (1), pp. 2221. Date of Electronic Publication: 2024 Aug 15.Publisher: BioMed Central Country of Publication: England NLM ID: 100968562 Publication Model: Electronic Cited Medium:

تفاصيل العنوان

Economic burden of tuberculosis in Tanzania: a national survey of costs faced by tuberculosis-affected households.

• Authors : Kilale, Andrew Martin¹ (AUTHOR) ; Pantoja, Andrea² (AUTHOR); Jani, Bhavin³ (AUTHOR)

Subjects: *HOUSEHOLDS; *PATIENT compliance; *TUBERCULOSISTANZANIA; SUB-Saharan Africa

• Source: BMC Public Health. 3/29/2022, Vol. 22 Issue 1, p1-10. 10p. 5 Charts, 2 Graphs.

تفاصيل العنوان

Rifapentine and isoniazid for prevention of tuberculosis in people with diabetes (PROTID): protocol for a randomised controlled trial.

• Authors : Ntinginya NE; Te Brake L ...

Subjects: Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/Diabetes Mellitus, Type 2*/epidemiology ; Isoniazid*/Isoniazid*/Isoniazid*/adverse effects ; Latent Tuberculosis*/Latent Tuberculosis*/Latent Tuberculosis*/prevention & control

• Source: Trials [Trials] 2022 Jun 10; Vol. 23 (1), pp. 480. Date of Electronic Publication: 2022 Jun 10.Publisher: BioMed Central Country of Publication: England NLM ID: 101263253 Publication Model: Electronic Cited Medium:

تفاصيل العنوان